The Latin America varicose vein device market is greatly underpenetrated and will see strong growth driven by economic growth and health care investments; the endovenous ablation market is already the highest grossing segment, and provides the largest opportunity for revenue growth over the forecast period.

This Medtech 360 Report provides key market metrics and high-level qualitative commentary for the varicose vein treatment device market in Latin America, including country-level data for seven major countries and aggregate data for the rest of Latin America, across a 10-year period.

Table of contents

  • Varicose Vein Treatment Devices - Market Insights - Latin America (Supplemental)

Author(s): Pankhil Gandhi, PharmD

Pankhil Gandhi is a research associate within the Cardiovascular Medtech Insights team at Decision Resources Group, specializing in transcatheter embolization and occlusion devices and deep venous disease treatment devices markets. Pankhil holds a Doctor of Pharmacy degree from the Babasaheb Ambedkar Marathwada University, Aurangabad.


Related Reports

Varicose Vein Treatment Devices - Market Insights - Europe (Supplemental)

The European varicose vein treatment device market remains underpenetrated and will see growth driven by the increasing adoption of minimally invasive procedures; the endovenous ablation market i...

View Details

Varicose Vein Treatment Devices - Market Insights - Europe

The European varicose vein treatment device market will be characterized by shift toward and a changing reimbursement landscape for endovenous ablation technologies, namely 

View Details

Varicose Vein Treatment Devices - Market Insights - United States

The US varicose vein treatment device market will be characterized by modest growth and a changing reimbursement landscape for new endovenous ablation technologies, which will compete with more e...

View Details

Varicose Vein Treatment Devices - Market Insights - Latin America

The Latin American varicose vein treatment device market will be characterized by low growth in minimally invasive procedures such as sclerotherapy and endovenous ablation technologies, which wil...

View Details